Cargando…

A web-based resource for designing therapeutics against Ebola Virus

In this study, we describe a web-based resource, developed for assisting the scientific community in designing an effective therapeutics against the Ebola virus. Firstly, we predicted and identified experimentally validated epitopes in each of the antigens/proteins of the five known ebolaviruses. Se...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhanda, Sandeep Kumar, Chaudhary, Kumardeep, Gupta, Sudheer, Brahmachari, Samir Kumar, Raghava, Gajendra P. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845023/
https://www.ncbi.nlm.nih.gov/pubmed/27113850
http://dx.doi.org/10.1038/srep24782
_version_ 1782428865101037568
author Dhanda, Sandeep Kumar
Chaudhary, Kumardeep
Gupta, Sudheer
Brahmachari, Samir Kumar
Raghava, Gajendra P. S.
author_facet Dhanda, Sandeep Kumar
Chaudhary, Kumardeep
Gupta, Sudheer
Brahmachari, Samir Kumar
Raghava, Gajendra P. S.
author_sort Dhanda, Sandeep Kumar
collection PubMed
description In this study, we describe a web-based resource, developed for assisting the scientific community in designing an effective therapeutics against the Ebola virus. Firstly, we predicted and identified experimentally validated epitopes in each of the antigens/proteins of the five known ebolaviruses. Secondly, we generated all the possible overlapping 9mer peptides from the proteins of ebolaviruses. Thirdly, conserved peptides across all the five ebolaviruses (four human pathogenic species) with no identical sequence in the human proteome, based on 1000 Genomes project, were identified. Finally, we identified peptide or epitope-based vaccine candidates that could activate both the B- and T-cell arms of the immune system. In addition, we also identified efficacious siRNAs against the mRNA transcriptome (absent in human transcriptome) of all the five ebolaviruses. It was observed that three species can potentially be targeted by a single siRNA (19mer) and 75 siRNAs can potentially target at least two species. A web server, EbolaVCR, has been developed that incorporates all the above information and useful computational tools (http://crdd.osdd.net/oscadd/ebola/).
format Online
Article
Text
id pubmed-4845023
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-48450232016-04-29 A web-based resource for designing therapeutics against Ebola Virus Dhanda, Sandeep Kumar Chaudhary, Kumardeep Gupta, Sudheer Brahmachari, Samir Kumar Raghava, Gajendra P. S. Sci Rep Article In this study, we describe a web-based resource, developed for assisting the scientific community in designing an effective therapeutics against the Ebola virus. Firstly, we predicted and identified experimentally validated epitopes in each of the antigens/proteins of the five known ebolaviruses. Secondly, we generated all the possible overlapping 9mer peptides from the proteins of ebolaviruses. Thirdly, conserved peptides across all the five ebolaviruses (four human pathogenic species) with no identical sequence in the human proteome, based on 1000 Genomes project, were identified. Finally, we identified peptide or epitope-based vaccine candidates that could activate both the B- and T-cell arms of the immune system. In addition, we also identified efficacious siRNAs against the mRNA transcriptome (absent in human transcriptome) of all the five ebolaviruses. It was observed that three species can potentially be targeted by a single siRNA (19mer) and 75 siRNAs can potentially target at least two species. A web server, EbolaVCR, has been developed that incorporates all the above information and useful computational tools (http://crdd.osdd.net/oscadd/ebola/). Nature Publishing Group 2016-04-26 /pmc/articles/PMC4845023/ /pubmed/27113850 http://dx.doi.org/10.1038/srep24782 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Dhanda, Sandeep Kumar
Chaudhary, Kumardeep
Gupta, Sudheer
Brahmachari, Samir Kumar
Raghava, Gajendra P. S.
A web-based resource for designing therapeutics against Ebola Virus
title A web-based resource for designing therapeutics against Ebola Virus
title_full A web-based resource for designing therapeutics against Ebola Virus
title_fullStr A web-based resource for designing therapeutics against Ebola Virus
title_full_unstemmed A web-based resource for designing therapeutics against Ebola Virus
title_short A web-based resource for designing therapeutics against Ebola Virus
title_sort web-based resource for designing therapeutics against ebola virus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845023/
https://www.ncbi.nlm.nih.gov/pubmed/27113850
http://dx.doi.org/10.1038/srep24782
work_keys_str_mv AT dhandasandeepkumar awebbasedresourcefordesigningtherapeuticsagainstebolavirus
AT chaudharykumardeep awebbasedresourcefordesigningtherapeuticsagainstebolavirus
AT guptasudheer awebbasedresourcefordesigningtherapeuticsagainstebolavirus
AT brahmacharisamirkumar awebbasedresourcefordesigningtherapeuticsagainstebolavirus
AT raghavagajendraps awebbasedresourcefordesigningtherapeuticsagainstebolavirus
AT dhandasandeepkumar webbasedresourcefordesigningtherapeuticsagainstebolavirus
AT chaudharykumardeep webbasedresourcefordesigningtherapeuticsagainstebolavirus
AT guptasudheer webbasedresourcefordesigningtherapeuticsagainstebolavirus
AT brahmacharisamirkumar webbasedresourcefordesigningtherapeuticsagainstebolavirus
AT raghavagajendraps webbasedresourcefordesigningtherapeuticsagainstebolavirus